9 METERS BIOPHARMA CEO John Temperato receives $2.1M in 2020

9 METERS BIOPHARMA reports 2020 executive compensation

By ExecPay News

Published: May 12, 2021

9 METERS BIOPHARMA reported fiscal year 2020 executive compensation information on May 12, 2021.
In 2020, four executives at 9 METERS BIOPHARMA received on average a compensation package of $1.1M, a 92% increase compared to previous year.
Average pay of disclosed executives at 9 METERS BIOPHARMA
John Temperato, Chief Executive Officer, received $2.1M in total. 61% of Temperato's compensation, or $1.3M, was in option awards. Temperato also received $159K in non-equity incentive plan, $329K in salary, as well as $327K in stock awards.
Patrick Griffin, M.D., F.A.C.P, Chief Medical Officer, received a compensation package of $950K, which decreased by 8% compared to previous year. 41% of the compensation package, or $393K, was in salary.
Edward J. Sitar, Chief Financial Officer, earned $779K in 2020, a 27% increase compared to previous year.
Sandeep Laumas, Chief Executive Officer, received $531K in 2020, which increases by 12% compared to 2019.

Related executives

John Temperato

9 METERS BIOPHARMA

Chief Executive Officer

Edward Sitar

9 METERS BIOPHARMA

Chief Financial Officer

Sandeep Laumas

9 METERS BIOPHARMA

Chief Executive Officer

Patrick FACP

9 METERS BIOPHARMA

Chief Medical Officer

You may also like

Source: SEC filing on May 12, 2021.